Atlas Trials

The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China

Clinical trial NCT06489184 · UNKNOWN

Trial details

NCT number
NCT06489184
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
CLL
Start date
2024-08-01
Primary completion
2025-06-01
Enrollment
490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.